0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Microbiome Market Research Report 2022
Published Date: June 2021
|
Report Code: QYRE-Auto-12A183
Home | Market Reports | Science| Biological Sciences
Global Human Microbiome Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Human Microbiome Market Research Report 2022

Code: QYRE-Auto-12A183
Report
June 2021
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Microbiome Market 

The global Human Microbiome market size is projected to reach USD 1544.9 Million by 2028, from USD 384.9 Million in 2021, at a CAGR of 21.7% during 2022-2028.

Human_Microbiome_Market

Human Microbiome Market Share

At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share. 

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.

An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome market.

 

Human Microbiome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

By Type

  • Gastrointestinal Tract Human Micobiome
  • Urogenital Tract Human Micobiome
  • Others

By Application

  • Treatment
  • Diagnosis

By Region

  • North America
  • US.
  • Canada
  • Europe
  • Germany
  • France
  • UK.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

By Company

  • Vedanta
  • Seres Therapeutics
  • Second Genome
  • Rebiotix
  • ActoGeniX
  • Enterome BioScience
  • AvidBiotics
  • 4D Pharma Research Ltd
  • Enterologics
  • Metabogen
  • Metabiomics
  • Ritter Pharmaceuticals
  • Osel
  • Symberix
  • Miomics
  • Symbiotix Biotherapies
  • MicroBiome Therapeutics LLC

Scope of Human Microbiome Market Report

Report Metric

Details

Report Name

Human Microbiome Market

Market size value in 2021

USD 384.9 Million

Revenue forecast in 2028

USD 1544.9 Million

Growth Rate

CAGR of 21.7%

Base year considered

2021

Forecast Period

2022-2028

By Type

Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome

By Application

Diagnosis, Treatment

Report Coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Type, Application, and Region

Geographic Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report 

1. How big is the Human Microbiome Market?

Ans. The global Human Microbiome market size is projected to reach US$ 1544.9 million by 2028, from US$ 384.9 million in 2021, at a CAGR of 21.7% during 2022-2028.

2. Who are the key players available in the Human Microbiome Industry?

Ans. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Market Perspective (2016-2027)
2.2 Human Microbiome Growth Trends by Regions
2.2.1 Human Microbiome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Microbiome Historic Market Share by Regions (2016-2021)
2.2.3 Human Microbiome Forecasted Market Size by Regions (2022-2027)
2.3 Human Microbiome Industry Dynamic
2.3.1 Human Microbiome Market Trends
2.3.2 Human Microbiome Market Drivers
2.3.3 Human Microbiome Market Challenges
2.3.4 Human Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Players by Revenue
3.1.1 Global Top Human Microbiome Players by Revenue (2016-2021)
3.1.2 Global Human Microbiome Revenue Market Share by Players (2016-2021)
3.2 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Revenue
3.4 Global Human Microbiome Market Concentration Ratio
3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2020
3.5 Human Microbiome Key Players Head office and Area Served
3.6 Key Players Human Microbiome Product Solution and Service
3.7 Date of Enter into Human Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Breakdown Data by Type
4.1 Global Human Microbiome Historic Market Size by Type (2016-2021)
4.2 Global Human Microbiome Forecasted Market Size by Type (2022-2027)
5 Human Microbiome Breakdown Data by Application
5.1 Global Human Microbiome Historic Market Size by Application (2016-2021)
5.2 Global Human Microbiome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Microbiome Market Size (2016-2027)
6.2 North America Human Microbiome Market Size by Type
6.2.1 North America Human Microbiome Market Size by Type (2016-2021)
6.2.2 North America Human Microbiome Market Size by Type (2022-2027)
6.2.3 North America Human Microbiome Market Size by Type (2016-2027)
6.3 North America Human Microbiome Market Size by Application
6.3.1 North America Human Microbiome Market Size by Application (2016-2021)
6.3.2 North America Human Microbiome Market Size by Application (2022-2027)
6.3.3 North America Human Microbiome Market Size by Application (2016-2027)
6.4 North America Human Microbiome Market Size by Country
6.4.1 North America Human Microbiome Market Size by Country (2016-2021)
6.4.2 North America Human Microbiome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Human Microbiome Market Size (2016-2027)
7.2 Europe Human Microbiome Market Size by Type
7.2.1 Europe Human Microbiome Market Size by Type (2016-2021)
7.2.2 Europe Human Microbiome Market Size by Type (2022-2027)
7.2.3 Europe Human Microbiome Market Size by Type (2016-2027)
7.3 Europe Human Microbiome Market Size by Application
7.3.1 Europe Human Microbiome Market Size by Application (2016-2021)
7.3.2 Europe Human Microbiome Market Size by Application (2022-2027)
7.3.3 Europe Human Microbiome Market Size by Application (2016-2027)
7.4 Europe Human Microbiome Market Size by Country
7.4.1 Europe Human Microbiome Market Size by Country (2016-2021)
7.4.2 Europe Human Microbiome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Market Size (2016-2027)
8.2 Asia-Pacific Human Microbiome Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Microbiome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Microbiome Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Microbiome Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Microbiome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Microbiome Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Microbiome Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Microbiome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Microbiome Market Size (2016-2027)
9.2 Latin America Human Microbiome Market Size by Type
9.2.1 Latin America Human Microbiome Market Size by Type (2016-2021)
9.2.2 Latin America Human Microbiome Market Size by Type (2022-2027)
9.2.3 Latin America Human Microbiome Market Size by Type (2016-2027)
9.3 Latin America Human Microbiome Market Size by Application
9.3.1 Latin America Human Microbiome Market Size by Application (2016-2021)
9.3.2 Latin America Human Microbiome Market Size by Application (2022-2027)
9.3.3 Latin America Human Microbiome Market Size by Application (2016-2027)
9.4 Latin America Human Microbiome Market Size by Country
9.4.1 Latin America Human Microbiome Market Size by Country (2016-2021)
9.4.2 Latin America Human Microbiome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Market Size (2016-2027)
10.2 Middle East & Africa Human Microbiome Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Microbiome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Microbiome Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Microbiome Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Microbiome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Microbiome Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Microbiome Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Microbiome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vedanta
11.1.1 Vedanta Company Details
11.1.2 Vedanta Business Overview
11.1.3 Vedanta Human Microbiome Introduction
11.1.4 Vedanta Revenue in Human Microbiome Business (2016-2021)
11.1.5 Vedanta Recent Development
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Details
11.2.2 Seres Therapeutics Business Overview
11.2.3 Seres Therapeutics Human Microbiome Introduction
11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2016-2021)
11.2.5 Seres Therapeutics Recent Development
11.3 Second Genome
11.3.1 Second Genome Company Details
11.3.2 Second Genome Business Overview
11.3.3 Second Genome Human Microbiome Introduction
11.3.4 Second Genome Revenue in Human Microbiome Business (2016-2021)
11.3.5 Second Genome Recent Development
11.4 Rebiotix
11.4.1 Rebiotix Company Details
11.4.2 Rebiotix Business Overview
11.4.3 Rebiotix Human Microbiome Introduction
11.4.4 Rebiotix Revenue in Human Microbiome Business (2016-2021)
11.4.5 Rebiotix Recent Development
11.5 ActoGeniX
11.5.1 ActoGeniX Company Details
11.5.2 ActoGeniX Business Overview
11.5.3 ActoGeniX Human Microbiome Introduction
11.5.4 ActoGeniX Revenue in Human Microbiome Business (2016-2021)
11.5.5 ActoGeniX Recent Development
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Details
11.6.2 Enterome BioScience Business Overview
11.6.3 Enterome BioScience Human Microbiome Introduction
11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2016-2021)
11.6.5 Enterome BioScience Recent Development
11.7 AvidBiotics
11.7.1 AvidBiotics Company Details
11.7.2 AvidBiotics Business Overview
11.7.3 AvidBiotics Human Microbiome Introduction
11.7.4 AvidBiotics Revenue in Human Microbiome Business (2016-2021)
11.7.5 AvidBiotics Recent Development
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Details
11.8.2 4D Pharma Research Ltd Business Overview
11.8.3 4D Pharma Research Ltd Human Microbiome Introduction
11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2016-2021)
11.8.5 4D Pharma Research Ltd Recent Development
11.9 Enterologics
11.9.1 Enterologics Company Details
11.9.2 Enterologics Business Overview
11.9.3 Enterologics Human Microbiome Introduction
11.9.4 Enterologics Revenue in Human Microbiome Business (2016-2021)
11.9.5 Enterologics Recent Development
11.10 Metabogen
11.10.1 Metabogen Company Details
11.10.2 Metabogen Business Overview
11.10.3 Metabogen Human Microbiome Introduction
11.10.4 Metabogen Revenue in Human Microbiome Business (2016-2021)
11.10.5 Metabogen Recent Development
11.11 Metabiomics
11.11.1 Metabiomics Company Details
11.11.2 Metabiomics Business Overview
11.11.3 Metabiomics Human Microbiome Introduction
11.11.4 Metabiomics Revenue in Human Microbiome Business (2016-2021)
11.11.5 Metabiomics Recent Development
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Details
11.12.2 Ritter Pharmaceuticals Business Overview
11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2016-2021)
11.12.5 Ritter Pharmaceuticals Recent Development
11.13 Osel
11.13.1 Osel Company Details
11.13.2 Osel Business Overview
11.13.3 Osel Human Microbiome Introduction
11.13.4 Osel Revenue in Human Microbiome Business (2016-2021)
11.13.5 Osel Recent Development
11.14 Symberix
11.14.1 Symberix Company Details
11.14.2 Symberix Business Overview
11.14.3 Symberix Human Microbiome Introduction
11.14.4 Symberix Revenue in Human Microbiome Business (2016-2021)
11.14.5 Symberix Recent Development
11.15 Miomics
11.15.1 Miomics Company Details
11.15.2 Miomics Business Overview
11.15.3 Miomics Human Microbiome Introduction
11.15.4 Miomics Revenue in Human Microbiome Business (2016-2021)
11.15.5 Miomics Recent Development
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Details
11.16.2 Symbiotix Biotherapies Business Overview
11.16.3 Symbiotix Biotherapies Human Microbiome Introduction
11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2016-2021)
11.16.5 Symbiotix Biotherapies Recent Development
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Details
11.17.2 MicroBiome Therapeutics LLC Business Overview
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2016-2021)
11.17.5 MicroBiome Therapeutics LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Gastrointestinal Tract Human Micobiome
    Table 3. Key Players of Urogenital Tract Human Micobiome
    Table 4. Key Players of Others
    Table 5. Global Human Microbiome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Human Microbiome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Human Microbiome Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Human Microbiome Market Share by Regions (2016-2021)
    Table 9. Global Human Microbiome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Human Microbiome Market Share by Regions (2022-2027)
    Table 11. Human Microbiome Market Trends
    Table 12. Human Microbiome Market Drivers
    Table 13. Human Microbiome Market Challenges
    Table 14. Human Microbiome Market Restraints
    Table 15. Global Human Microbiome Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Human Microbiome Market Share by Players (2016-2021)
    Table 17. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2020)
    Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Human Microbiome Product Solution and Service
    Table 22. Date of Enter into Human Microbiome Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Human Microbiome Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Human Microbiome Revenue Market Share by Type (2016-2021)
    Table 26. Global Human Microbiome Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Human Microbiome Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Human Microbiome Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Human Microbiome Revenue Market Share by Application (2016-2021)
    Table 30. Global Human Microbiome Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Human Microbiome Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Human Microbiome Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Human Microbiome Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
    Table 37. North America Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
    Table 38. Europe Human Microbiome Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Human Microbiome Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
    Table 43. Europe Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
    Table 44. Asia-Pacific Human Microbiome Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Human Microbiome Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Human Microbiome Market Size by Region (2016-2021) & (US$ Million)
    Table 49. Asia-Pacific Human Microbiome Market Size by Region (2022-2027) & (US$ Million)
    Table 50. Latin America Human Microbiome Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Human Microbiome Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
    Table 55. Latin America Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
    Table 56. Middle East & Africa Human Microbiome Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Human Microbiome Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Human Microbiome Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Human Microbiome Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Human Microbiome Market Size by Country (2016-2021) & (US$ Million)
    Table 61. Middle East & Africa Human Microbiome Market Size by Country (2022-2027) & (US$ Million)
    Table 62. Vedanta Company Details
    Table 63. Vedanta Business Overview
    Table 64. Vedanta Human Microbiome Product
    Table 65. Vedanta Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 66. Vedanta Recent Development
    Table 67. Seres Therapeutics Company Details
    Table 68. Seres Therapeutics Business Overview
    Table 69. Seres Therapeutics Human Microbiome Product
    Table 70. Seres Therapeutics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 71. Seres Therapeutics Recent Development
    Table 72. Second Genome Company Details
    Table 73. Second Genome Business Overview
    Table 74. Second Genome Human Microbiome Product
    Table 75. Second Genome Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 76. Second Genome Recent Development
    Table 77. Rebiotix Company Details
    Table 78. Rebiotix Business Overview
    Table 79. Rebiotix Human Microbiome Product
    Table 80. Rebiotix Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 81. Rebiotix Recent Development
    Table 82. ActoGeniX Company Details
    Table 83. ActoGeniX Business Overview
    Table 84. ActoGeniX Human Microbiome Product
    Table 85. ActoGeniX Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 86. ActoGeniX Recent Development
    Table 87. Enterome BioScience Company Details
    Table 88. Enterome BioScience Business Overview
    Table 89. Enterome BioScience Human Microbiome Product
    Table 90. Enterome BioScience Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 91. Enterome BioScience Recent Development
    Table 92. AvidBiotics Company Details
    Table 93. AvidBiotics Business Overview
    Table 94. AvidBiotics Human Microbiome Product
    Table 95. AvidBiotics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 96. AvidBiotics Recent Development
    Table 97. 4D Pharma Research Ltd Company Details
    Table 98. 4D Pharma Research Ltd Business Overview
    Table 99. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 100. 4D Pharma Research Ltd Recent Development
    Table 101. Enterologics Company Details
    Table 102. Enterologics Business Overview
    Table 103. Enterologics Human Microbiome Product
    Table 104. Enterologics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 105. Enterologics Recent Development
    Table 106. Metabogen Company Details
    Table 107. Metabogen Business Overview
    Table 108. Metabogen Human Microbiome Product
    Table 109. Metabogen Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 110. Metabogen Recent Development
    Table 111. Metabiomics Company Details
    Table 112. Metabiomics Business Overview
    Table 113. Metabiomics Human Microbiome Product
    Table 114. Metabiomics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 115. Metabiomics Recent Development
    Table 116. Ritter Pharmaceuticals Company Details
    Table 117. Ritter Pharmaceuticals Business Overview
    Table 118. Ritter Pharmaceuticals Human Microbiome Product
    Table 119. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 120. Ritter Pharmaceuticals Recent Development
    Table 121. Osel Company Details
    Table 122. Osel Business Overview
    Table 123. Osel Human Microbiome Product
    Table 124. Osel Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 125. Osel Recent Development
    Table 126. Symberix Company Details
    Table 127. Symberix Business Overview
    Table 128. Symberix Human Microbiome Product
    Table 129. Symberix Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 130. Symberix Recent Development
    Table 131. Miomics Company Details
    Table 132. Miomics Business Overview
    Table 133. Miomics Human Microbiome Product
    Table 134. Miomics Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 135. Miomics Recent Development
    Table 136. Symbiotix Biotherapies Company Details
    Table 137. Symbiotix Biotherapies Business Overview
    Table 138. Symbiotix Biotherapies Human Microbiome Product
    Table 139. Symbiotix Biotherapies Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 140. Symbiotix Biotherapies Recent Development
    Table 141. MicroBiome Therapeutics LLC Company Details
    Table 142. MicroBiome Therapeutics LLC Business Overview
    Table 143. MicroBiome Therapeutics LLC Human Microbiome Product
    Table 144. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2016-2021) & (US$ Million)
    Table 145. MicroBiome Therapeutics LLC Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Microbiome Market Share by Type: 2020 VS 2027
    Figure 2. Gastrointestinal Tract Human Micobiome Features
    Figure 3. Urogenital Tract Human Micobiome Features
    Figure 4. Others Features
    Figure 5. Global Human Microbiome Market Share by Application: 2020 VS 2027
    Figure 6. Treatment Case Studies
    Figure 7. Diagnosis Case Studies
    Figure 8. Human Microbiome Report Years Considered
    Figure 9. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Human Microbiome Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Human Microbiome Market Share by Regions: 2020 VS 2027
    Figure 12. Global Human Microbiome Market Share by Regions (2022-2027)
    Figure 13. Global Human Microbiome Market Share by Players in 2020
    Figure 14. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2020
    Figure 16. Global Human Microbiome Revenue Market Share by Type (2016-2021)
    Figure 17. Global Human Microbiome Revenue Market Share by Type (2022-2027)
    Figure 18. North America Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Human Microbiome Market Share by Type (2016-2027)
    Figure 20. North America Human Microbiome Market Share by Application (2016-2027)
    Figure 21. North America Human Microbiome Market Share by Country (2016-2027)
    Figure 22. United States Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Human Microbiome Market Share by Type (2016-2027)
    Figure 26. Europe Human Microbiome Market Share by Application (2016-2027)
    Figure 27. Europe Human Microbiome Market Share by Country (2016-2027)
    Figure 28. Germany Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Human Microbiome Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Human Microbiome Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Human Microbiome Market Share by Region (2016-2027)
    Figure 38. China Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Human Microbiome Market Share by Type (2016-2027)
    Figure 46. Latin America Human Microbiome Market Share by Application (2016-2027)
    Figure 47. Latin America Human Microbiome Market Share by Country (2016-2027)
    Figure 48. Mexico Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Human Microbiome Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Human Microbiome Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Human Microbiome Market Share by Country (2016-2027)
    Figure 54. Turkey Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Human Microbiome Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Vedanta Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 58. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 59. Second Genome Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 60. Rebiotix Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 61. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 62. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 63. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 64. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 65. Enterologics Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 66. Metabogen Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 67. Metabiomics Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 68. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 69. Osel Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 70. Symberix Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 71. Miomics Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 72. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 73. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RNA and DNA Extraction Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36Z8348
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global DNA Library Preparation Kits Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5U6259
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Edible Insects Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20A9325
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global DNA Repair Proteins And Reagents Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9S9524
Mon Apr 15 00:00:00 UTC 2024

Add to Cart